Neuromodulation as an anticancer strategy
Cancer Medicine · 2023-11 · 12 (21) · 20521-20522
DOI: 10.1002/cam4.6624 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cancer Medicine, online erschienen am 17.10.2023. Verfasst von Ashwin Kumaria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
There may be a role for vagus nerve stimulation as an anticancer strategy. This may include the modulation of signalling between nerves and tumour cells and epigenetic influences, in addition to reduction of oxidative stress, anti‐inflammatory and endocrine mechanisms.
Autor:innen und Institutionen
- Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK.
- Department of Neurosurgery, King's College Hospital, London, UK.
ORCID-Profile: Ashwin Kumaria, Keyoumars Ashkan
Zitieren
APA
Kumaria, A., & Ashkan, K. (2023). Neuromodulation as an anticancer strategy. Cancer Medicine, 12(21), 20521-20522. https://doi.org/10.1002/cam4.6624
Vancouver
Kumaria A, Ashkan K. Neuromodulation as an anticancer strategy. Cancer Medicine. 2023;12(21):20521-20522. doi:10.1002/cam4.6624
BibTeX
@article{Kumaria2023,
author = {Kumaria, Ashwin and Ashkan, Keyoumars},
title = {Neuromodulation as an anticancer strategy},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {21},
pages = {20521--20522},
doi = {10.1002/cam4.6624}
}
EUVIMED